Atai Life Sciences Long Term Debt 2020-2024 | ATAI

Atai Life Sciences long term debt from 2020 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Atai Life Sciences Annual Long Term Debt
(Millions of US $)
2023 $19
2022 $15
2021 $1
2020 $2
2019 $0
Atai Life Sciences Quarterly Long Term Debt
(Millions of US $)
2024-03-31 $21
2023-12-31 $19
2023-09-30 $16
2023-06-30 $16
2023-03-31 $16
2022-12-31 $15
2022-09-30 $15
2022-06-30 $1
2022-03-31 $2
2021-12-31 $1
2021-09-30 $1
2021-06-30 $1
2021-03-31 $2
2020-12-31 $2
2020-09-30
2020-06-30
2020-03-31
2019-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.273B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.097B 10.34
Quest Diagnostics (DGX) United States $15.557B 16.08
DaVita (DVA) United States $11.598B 14.41
Encompass Health (EHC) United States $8.513B 21.79
Chemed (CHE) United States $8.407B 26.06
Elanco Animal Health (ELAN) United States $8.149B 21.14
Option Care Health (OPCH) United States $4.971B 18.82
RadNet (RDNT) United States $4.259B 88.69
Amedisys (AMED) United States $3.144B 22.27
LifeStance Health (LFST) United States $2.217B 0.00
Astrana Health (ASTH) United States $2.112B 28.55
Addus HomeCare (ADUS) United States $1.785B 25.54
U.S Physical Therapy (USPH) United States $1.515B 40.54
Pennant (PNTG) United States $0.681B 35.97
Aveanna Healthcare Holdings (AVAH) United States $0.521B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.016B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00